M. Chaparro, P. Martínez-Montiel, M. Van Domselaar, F. Bermejo, J. L

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

How do psychological variables influence coping strategies in inflammatory bowel disease? Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

National Guidelines for Nursing Delegation

Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum? Tamás Molnár, Klaudia Farkas, Ferenc.

Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.

Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody?

YouTube® and inflammatory bowel disease

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Ineffectiveness of infliximab therapy in severe infantile Crohn's disease Nuray Uslu, Yusuf Usta, Inci Nur Saltik-Temizel, Hulya Demir, Figen Gürakan,

Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature Gurhan.

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis Vincent Billioud, Alexander C. Ford,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series Erik Mooiweer,

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) Mariam Aguas, Vicente Garrigues,

A. J. Walsh, M. Weltman, D. Burger, S. Vivekanandarajah, S. Connor, M

Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants T. Felekis, K.H. Katsanos, C.D. Zois,

The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD) S. Malik, S.F. Ahmed, M.L. Wilson, N. Shah, S. Loganathan,

Serum prohepcidin levels in chronic inflammatory bowel diseases

Oral tacrolimus for pediatric steroid-resistant ulcerative colitis

Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,

Charlotte de Bie, Angelika Kindermann, Johanna Escher

N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard

Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,

Fatal Colonic Perforation in a Pregnant with Behçet's Disease

Valle García-Sánchez, Eva Iglesias-Flores, Raúl González, Javier P

Public awareness of Crohn's disease and ulcerative colitis: A national survey Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,

B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases Danuta Owczarek,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Gord Blackhouse, Nazila Assasi,

Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature Dana Duricova, Johan Burisch,

Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis Thomas W. Lee, Michael.

A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: Infliximab and surgery G. Andrisani, L. Guidi, A. Papa, A.E. Potenza,

Nitsan Maharshak, Scott E. Plevy

Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H

The usefulness of factor XIII levels in Crohn's disease

Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients Marko Brinar, Séverine.

Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis Niels Teich, Tobias Klugmann Journal of.

Seth Lipka, Seymour Katz, Lev Ginzburg Journal of Crohn's and Colitis

Osteoporosis in inflammatory bowel disease

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis M. De Vos, O. Dewit, G. D'Haens,

Pediatric pulmonary Crohn's disease: More frequent than expected

Ulrich Bonse-Geuking, Michael Kraus Journal of Crohn's and Colitis

Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation Sjoerd F. Bakker,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Gord Blackhouse, Nazila Assasi,

Comparative Effectiveness Research

Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.

Does active smoking really influence the course of Crohn's disease

Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function Ulf Hindorf, Malin Lindqvist.

Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms Mariëlle.

Yinghong Wang, Hua Gong, Rocio Lopez, Lei Lian, Ravi P. Kiran, Edy E

Surgical management of gluteal metastatic cutaneous Crohn's disease

Complete remission of a primary rectal lymphoma on ulcerative colitis, after withdrawal of azathioprine and infliximab Antonio López San Román, Manuel.

Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis S.D. McLaughlin, A. Culkin,

Volume 26, Issue 2, Pages (February 2018)

Bowel sonography in occlusive Crohn's disease

The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China Yue Li, Li-fan Zhang, Xiao-qing.

Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors Anilga Moradkhani, Linda.

Volume 133, Issue 2, Pages (August 2007)

Support Your Specialty

Issue Highlights Clinical Gastroenterology and Hepatology

Volume 17, Issue 2, Pages (February 1950)

Volume 69, Issue 3, Pages (February 2006)

Reviewer Acknowledgment

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Volume 4, Issue 1, Pages 2-3 (February 2006)

Quiz page December 2003 American Journal of Kidney Diseases

Presentation transcript:

Intensification of infliximab therapy in Crohn's disease: Efficacy and safety M.Chaparro, P. Martínez-Montiel, M. Van Domselaar, F. Bermejo, J.L. Pérez-Calle, B. Casis, A. López-San Román, A. Algaba, J. Maté, J.P. Gisbert Journal of Crohn's and Colitis Volume 6, Issue 1, Pages 62-67 (February 2012) DOI: 10.1016/j.crohns.2011.07.005 Copyright © 2011 Terms and Conditions

Figure 1 Kaplan–Meier curve for time to loss of efficacy to the escalated dosage of infliximab in patients with an initial response. Journal of Crohn's and Colitis 2012 6, 62-67DOI: (10.1016/j.crohns.2011.07.005) Copyright © 2011 Terms and Conditions